Stay updated with breaking news from Ahmed enayetallah. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BlueRock Therapeutics has exercised its exclusive option to license induced pluripotent stem cell (iPSC)-derived cell therapy candidate from FUJIFILM. ....
BlueRock Therapeutics, a clinical-stage cell therapy company and subsidiary of Bayer, announced that it has exercised its option for an exclusive license to OpCT-001 for the treatment of primary. ....
BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for treating Primary Photoreceptor Diseases from FUJIFILM Cellular Dynamics and Opsis Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Bayer and BlueRock announce positive results from Parkinson's cell therapy trial pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose. ....